biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Which happens first?

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Feb 12, 2021 10:56pm

135 Views

Post# 32560567

RE:RE:RE:RE:RE:RE:RE:Which happens first?

zwerp2000 wrote: Don't mind me, JD. Focus on your website and this brilliant piece you are eventually going to release on bioaf. We are all waiting....and waiting....and waiting. Yawn

Fuk you are an annoying little child Twerp2000. Sell your shares , move on, grow up and get a life you clown.

<< Previous

Bullboard Posts

Next >>

Canada Nickel unveils second of seven resources planned by mid-2025